3-(TERT-BUTOXYCARBONYL)-3-AZABICYCLO[3.1.1]HEPTANE-6-CARBOXYLIC ACID, 95.0%, 1g

2-Chloro-5-(trifluoromethyl)pyridin-4-amine, 95.0%, 100g

(S)-1-(4-(4-Methylthiazol-5-yl)phenyl)ethan-1-amine dihydrochloride, 5g

2-Hydroxy-5-methyl-3-nitropyridine>98.0%(GC)(T)5g

N,N-dimethylacetamide, ROTICHROM® GC , 5 ml, glass packaging

beta-Bromostyrene (cis- and trans- mixture)>95.0%(GC)25g

(S)-3-Amino-2-methylpropanoic acid, 95.0%, 1g

3-Benzamidopropanoic acid, 95.0%, 100g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 500m2/g)25g

2-(4,6-Dichloropyrimidin-5-yl)ethanol, 95.0%, 1g

1-Methyl-3-phenyl-1H-1,2,4-triazole-5-carbaldehyde, 97%, 1g

Bis(furan-2-ylmethyl)sulfane, 98.0%, 100g

(4-Aminopiperidin-1-yl)(pyrrolidin-1-yl)methanone hydrochloride, 95.0%, 1g